BioCloner Health
+ business areaBioPharma R&D+Services
+ annual revenue
2019 - 13,000,000 PLN
2020 - 10,000,000 PLN
2021 - 8,000,000 PLN
2022 - 143,400 PLN
2023 - 162,000 PLN
2024 - 166,700 PLN
+ workforce (estimated if not reported)
2024 - 14
+ depreciation & amortization
2018 - 334,300 PLN
2019 - 308,000 PLN
2020 - 38,100 PLN
2021 - 69,100 PLN
2022 - 62,500 PLN
2023 - 70,600 PLN
2024 - 115,800 PLN
Develops biotechnology solutions for regenerative medicine with activities including laboratory, office, and manufacturing in Warsaw and Lublin.